An Open Label, Multicenter Extension Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella B)
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2019
Price : $35 *
At a glance
- Drugs Atezolizumab (Primary) ; Antineoplastics; Cobimetinib
- Indications Cancer
- Focus Therapeutic Use
- Acronyms IMbrella B
- Sponsors Roche
- 12 Mar 2019 Status changed from not yet recruiting to recruiting.
- 12 Feb 2019 Planned initiation date changed from 25 Jan 2019 to 28 Feb 2019.
- 14 Jan 2019 Planned initiation date changed from 31 Dec 2018 to 25 Jan 2019.